Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 2/20 | 0.46 |
| ▸ | CA5A | P35218 | 2/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.42 |
| ▸ | HPGD | P15428 | 5/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25328798 | 0.75 | KDM4E (0.41) | CA12CA1CA2CA4CA6 | |
| SCHEMBL646614 | 0.73 | KDM4E (0.43) | CA12CA1CA2CA4CA6 | |
| SCHEMBL646616 | 0.73 | KDM4E (0.43) | CA12CA1CA2CA4CA6 | |
| SCHEMBL647361 | 0.72 | KDM4E (0.40) | CA12CA1CA2CA4CA6 | |
| SCHEMBL647363 | 0.72 | KDM4E (0.40) | CA12CA1CA2CA4CA6 | |
| SCHEMBL2290699 | 0.71 | KDM4E (0.51) | CA12CA1CA2CA4CA6 | |
| SCHEMBL21817004 | 0.71 | KDM4E (0.48) | CA12CA1CA2CA4CA6 | |
| SCHEMBL21817001 | 0.71 | KDM4E (0.48) | CA12CA1CA2CA4CA6 | |
| SCHEMBL3789794 | 0.70 | KDM4E (0.65) | CA12CA1CA2CA4CA6 | |
| SCHEMBL3789790 | 0.70 | KDM4E (0.65) | CA12CA1CA2CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2010-02-25 | — | — | US | claimed |
| WO-2008083975-A1 | LIGHT-STABILIZED COMPOSITION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2008083974-A1 | ACTIVE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2008067928-A1 | UV ABSORBING COMPOSITIONS CONTAINING A PYRROLYLTRIAZINE | ISDIN S.A. (ES) | 2008-06-12 | — | — | WO | claimed |
| US-10406135-B2 | Compositions containing isosorbide monoester and alcohols that contain at least one aromatic group | CLARIANT INTERNATIONAL LTD. (CH) | 2019-09-10 | — | — | US | disclosed |
| US-9834635-B2 | Polymers based on arcrylic, methacrylic or ethacrylic amidoalkyl sulfonic acid or salts and carboxyalky acrylate, methacrylate or ethacrylate or oligomers of said carboxy compounds | CLARIANT INTERNATIONAL LTD. (CH) | 2017-12-05 | — | — | US | disclosed |
| US-9526687-B2 | Polymers based on sulfonic acids, amides and special cross-linking agents | CLARIANT INTERNATIONAL LTD. (CH) | 2016-12-27 | — | — | US | disclosed |
| US-9295626-B2 | Compositions comprising isosorbide monoester and N-hydroxypyridones | CLARIANT INTERNATIONAL LTD. (CH) | 2016-03-29 | — | — | US | disclosed |
| US-20160000080-A1 | COMPOSITIONS CONTAINING ISOSORBIDE MONOESTER AND ALIPHATIC VICINAL DIOLS | CLARIANT INTERNATIONAL LTD. (CH) | 2016-01-07 | — | — | US | disclosed |
| US-20150342856-A1 | Cationic Comb Copolymers, Preparation Thereof And Use Thereof In Cosmetic, Pharmaceutical And Dermatological Formulations | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-12-03 | — | — | US | disclosed |
| US-20140369943-A1 | COMPOSITIONS COMPRISING ISOSORBIDE MONOESTERS AND HALOGENATED ANTIMICROBIAL ACTIVE COMPOUNDS | CLARIANT INTERNATIONAL LTD. (CH) | 2014-12-18 | — | — | US | disclosed |
| US-20140348763-A1 | COMPOSITIONS CONTAINING ISOSORBIDE MONOESTER AND ALCOHOLS THAT CONTAIN AT LEAST ONE AROMATIC GROUP | CLARIANT INTERNATIONAL LTD. (CH) | 2014-11-27 | — | — | US | disclosed |
| WO-2008083975-A1 | LIGHT-STABILIZED COMPOSITION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | disclosed |
| WO-2008083974-A1 | ACTIVE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | disclosed |
| WO-2008067928-A1 | UV ABSORBING COMPOSITIONS CONTAINING A PYRROLYLTRIAZINE | ISDIN S.A. (ES) | 2008-06-12 | — | — | WO | disclosed |
| US-20080009429-A1 | Cosmetic or dermatological cleansing compositions comprising secondary alkanesulfonates | CLARIANT INTERNATIONAL LTD. | 2008-01-10 | — | — | US | disclosed |
| US-20070116654-A1 | Cosmetics | SHISEIDO CO., LTD. | 2007-05-24 | — | — | US | disclosed |
| US-7169379-B2 | Cosmetics | SHISEIDO CO., LTD. (JP) | 2007-01-30 | — | — | US | disclosed |
| EP-1352638-A1 | COSMETICS | SHISEIDO COMPANY, LTD. (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-20030185772-A1 | Cosmetics | SHISEIDO COMPANY, LTD. (JP) | 2003-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140348763-A1 | COMPOSITIONS CONTAINING ISOSORBIDE MONOESTER AND ALCOHOLS THAT CONTAIN AT LEAST ONE AROMATIC GROUP | ADH5, ADH1A, ADH1C | CA12 4313/4885CA1 4579/4885CA2 4551/4885 |
| US-20160000080-A1 | COMPOSITIONS CONTAINING ISOSORBIDE MONOESTER AND ALIPHATIC VICINAL DIOLS | HSD17B12, DHCR7, ERG28 | CA12 2862/4885CA1 2903/4885CA2 3737/4885 |
| US-20150342856-A1 | Cationic Comb Copolymers, Preparation Thereof And Use Thereof In Cosmetic, Pharmaceutical And Dermatological Formulations | C9, PARN, SGMS1 | CA12 1900/4885CA1 2968/4885CA2 949/4885 |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | UGT2B17, TACR2, UGT1A1 | CA12 1110/4885CA1 2294/4885CA2 3587/4885 |
| US-10406135-B2 | Compositions containing isosorbide monoester and alcohols that contain at least one aromatic group | ADH5, ADH1A, ADH1C | CA12 4313/4885CA1 4579/4885CA2 4551/4885 |
| US-20140369943-A1 | COMPOSITIONS COMPRISING ISOSORBIDE MONOESTERS AND HALOGENATED ANTIMICROBIAL ACTIVE COMPOUNDS | FASN, HSD17B12, ELOVL3 | CA12 4364/4885CA1 4658/4885CA2 4630/4885 |
| US-20080009429-A1 | Cosmetic or dermatological cleansing compositions comprising secondary alkanesulfonates | SMURF1, SMURF2, CUTA | CA12 3106/4885CA1 4299/4885CA2 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.